Therefore, a better understanding of how to preserve sGC activity as well as a better understanding of the interplay between stretch-mediated oxidative injury and the iNOS-sGC pathway in PASMC could provide key insights into future avenues to treat infants with pulmonary hypertension. This evidence concerns the gene NOS2 and pulmonary hypertension.